SporesBiotics Formula combines 3 probiotic strains in spore form — Bacillus clausii, Bacillus subtilis and Bacillus coagulans — delivering 10 billion CFU per day.*
Protected by their natural spore coat, these probiotics are designed to survive stomach acidity and reach the intestine, where they can work synergistically to help support microbiota balance and digestive comfort.*
SporesBiotics Formula is part of our Digestive & Gut Health category.*
Key Benefits of Spore-Forming Probiotics*
- Bacillus clausii — studied for its role in helping restore and maintain microbiota balance, particularly after digestive stress or antibiotic use.*
- Bacillus subtilis — researched for its potential to support intestinal defences and help maintain a balanced gut environment.*
- Bacillus coagulans — may help promote enzyme production and digestive comfort, while supporting overall intestinal well-being.*
4 Strengths of SporesBiotics Formula*
- Spore protection: resistant spores ensure survival through stomach acid and targeted release in the intestine.*
- Synergistic blend: three complementary strains selected for their potential to support gut and immune balance.*
- Powerful dosage: provides 10 billion CFU per day for effective support.*
- Gastro-resistant capsules: designed for added protection and optimal delivery in the intestine.*
WARNINGS
Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used as a substitute for a varied and balanced diet or a healthy lifestyle.
STORAGE
Store in a cool, dry place away from direct sunlight, heat, and humidity.
Keep out of reach of children.
PREGNANCY AND MEDICAL CONDITIONS
If you are pregnant, breastfeeding, or have any medical conditions, consult your healthcare provider before using this product.
SUPPLEMENT INTERACTIONS
Consult your healthcare provider before use, especially if you are taking any medications or other supplements as there may be potential interactions.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Daily dose: 2 capsules
Number of doses per box: 30
|
Daily dose
|
|
Bacillus subtilis LMGS 31763
|
3.75 × 10⁹ CFU
|
|
Bacillus coagulans (Heyndrickxia coagulans) LMGS 30832
|
3.75 × 10⁹ CFU
|
|
Bacillus clausii (Alkalihalobacillus clausii) UBCC07
|
2.5 × 10⁹ CFU
|
|
Other ingredients: hypromellose capsule, acacia gum.
|
Serving size: Take 2 capsules per day, 30 minutes before meals. Each capsule contains 5 billion probiotics.
Servings per container: 30
Storage: Store away from direct light, heat, and humidity.
Cautions: For adults only. Do not exceed the recommended daily dose. Keep out of reach of children. Consult a healthcare provider before taking this supplement and if you are pregnant, breastfeeding, or having health concerns.*
This product is a dietary supplement and should not be used as a substitute for a varied, balanced diet and a healthy lifestyle.
- Abbrescia A, Palese LL, Papa S, Gaballo A, Alifano P, Sardanelli AM. ... Bacillus clausii Strains in Commercial Preparation. Curr Med Chem. 2014 Dec;1(2):102–10. doi: 10.2174/2212707002666150128195631. Epub 2014 Dec. PMCID: PMC5388794.
- Ahire JJ, Kashikar MS, Madempudi RS. ... Germination of Bacillus clausii UBBC07 Spores in in vitro Human ... . Front Microbiol. 2020 Jun 10;11:1010. doi: 10.3389/fmicb.2020.01010. PMID: 32733389; PMCID: PMC7358638.
- E. Ghelardi, F. Celandroni, S. Salvetti, S.A. Gueye, A. Lupetti, S. Senesi, ... and persistence of Bacillus clausii in the human ... , Journal of Applied Microbiology, Volume 119, Issue 2, 1 August 2015, Pages 552–559, https://doi.org/10.1111/jam.12848
- Nista EC, Candelli M, Cremonini F, Cazzato IA, Zocco MA, Franceschi F, Cammarota G, Gasbarrini G, Gasbarrini A. Bacillus clausii ... : randomized, double-blind, placebo controlled trial. Aliment Pharmacol Ther. 2004 Nov 15;20(10):1181-8. doi: 10.1111/j.1365-2036.2004.02274.x. PMID: 15569121.
- Nannan C, Vu HQ, Gillis A, Caulier S, Nguyen TTT, Mahillon J. Bacilysin within the Bacillus subtilis group: gene prevalence versus ... . J Biotechnol. 2021 Feb 10;327:28-35. doi: 10.1016/j.jbiotec.2020.12.017. Epub 2020 Dec 30. PMID: 33387595.
- Bóka, B., Manczinger, L., Kocsubé, S. et al. Genome analysis of a Bacillus subtilis strain reveals genetic ... determining biocontrol properties. World J Microbiol Biotechnol 35, 52 (2019). https://doi.org/10.1007/s11274-019-2625-x
- Kallur RK, Madapati S, Mathur A, Bhattacharya S. The role of Weizmannia (Bacillus) coagulans LMG S-31876 in ... . Front Nutr. 2024 Feb 5;10:1310462. doi: 10.3389/fnut.2023.1310462. PMID: 38375355; PMCID: PMC10875997.
- Skrzydło-Radomańska B, Prozorow-Król B, Kurzeja-Mirosław A, Cichoż-Lach H, Laskowska K, Majsiak E, Bierła JB, Agnieszka S, Cukrowska B. The ... of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in ... - A Randomized Double-Blind Placebo-Controlled Three-Arm Interventional Trial. J Clin Med. 2023 Jul 22;12(14):4838. doi: 10.3390/jcm12144838. PMID: 37510953; PMCID: PMC10381776.
- Gupta AK, Maity C. ... of Bacillus coagulans LBSC ... : A prospective, interventional, randomized, double-blind, placebo-controlled clinical study [CONSORT Compliant]. Medicine (Baltimore). 2021 Jan 22;100(3):e23641. doi: 10.1097/MD.0000000000023641. PMID: 33545934; PMCID: PMC7837859.
